6-K Filing
Filing Information
| Form Type | 6-K |
| Accession Number | 0000950170-22-012342 |
| Period End Date | 20220331 |
| Filing Date | 20220630 |
| Fiscal Year | N/A |
| Fiscal Period | N/A |
| XBRL Instance | rnlx-20220630_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
65 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Common stock par or stated value per share |
CommonStockParOrStatedValuePerShare
|
0.00 | GBP | Point-in-time |
| Common stock par or stated value per share |
CommonStockParOrStatedValuePerShare
|
0.00 | GBP | Point-in-time |
| Common stock shares authorized |
CommonStockSharesAuthorized
|
76.87M | shares | Point-in-time |
| Common stock shares authorized |
CommonStockSharesAuthorized
|
76.87M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$32.36M | USD | Point-in-time |
| Common stock shares issued |
CommonStockSharesIssued
|
72.20M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$65.13M | USD | Point-in-time |
| Common stock shares issued |
CommonStockSharesIssued
|
72.31M | shares | Point-in-time |
| Common stock shares outstanding |
CommonStockSharesOutstanding
|
72.31M | shares | Point-in-time |
| Accounts receivable |
AccountsReceivableNetCurrent
|
$594.00K | USD | Point-in-time |
| Common stock shares outstanding |
CommonStockSharesOutstanding
|
72.20M | shares | Point-in-time |
| Accounts receivable |
AccountsReceivableNetCurrent
|
$1.01M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$993.00K | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$3.84M | USD | Point-in-time |
| Note receivable from Kantaro |
NotesReceivableRelatedPartiesCurrent
|
$75.00K | USD | Point-in-time |
| Note receivable from Kantaro |
NotesReceivableRelatedPartiesCurrent
|
$75.00K | USD | Point-in-time |
| Receivable from affiliates |
DueFromAffiliateCurrent
|
$1.00K | USD | Point-in-time |
| Receivable from affiliates |
DueFromAffiliateCurrent
|
$1.00K | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$66.79M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$37.28M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$2.49M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$2.85M | USD | Point-in-time |
| Investment in VericiDx |
InvestmentsInAndAdvancesToAffiliatesAtFairValue
|
$9.29M | USD | Point-in-time |
| Investment in VericiDx |
InvestmentsInAndAdvancesToAffiliatesAtFairValue
|
$4.32M | USD | Point-in-time |
| Investment in Kantaro |
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
$11.00K | USD | Point-in-time |
| Total assets |
Assets
|
$78.58M | USD | Point-in-time |
| Total assets |
Assets
|
$44.47M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$2.06M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$1.40M | USD | Point-in-time |
| Accounts payable-related party |
AccountsPayableRelatedPartiesCurrent
|
$361.00K | USD | Point-in-time |
| Accounts payable-related party |
AccountsPayableRelatedPartiesCurrent
|
$1.01M | USD | Point-in-time |
| Accrued expenses and other current liabilities |
AccruedLiabilitiesCurrent
|
$6.69M | USD | Point-in-time |
| Accrued expenses and other current liabilities |
AccruedLiabilitiesCurrent
|
$4.60M | USD | Point-in-time |
| Accrued expensesrelated party |
AccruedExpensesRelatedPartyCurrent
|
$5.03M | USD | Point-in-time |
| Accrued expensesrelated party |
AccruedExpensesRelatedPartyCurrent
|
$224.00K | USD | Point-in-time |
| Deferred revenue |
DeferredRevenueCurrent
|
$122.00K | USD | Point-in-time |
| Deferred revenue |
DeferredRevenueCurrent
|
$67.00K | USD | Point-in-time |
| Payable to affiliatecurrent |
DueToAffiliateCurrent
|
$350.00K | USD | Point-in-time |
| Payable to affiliatecurrent |
DueToAffiliateCurrent
|
$187.00K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$15.04M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$7.06M | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$53.00K | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$14.00K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$15.05M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$7.12M | USD | Point-in-time |
| Commitments and contingencies (Note 8) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 8) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Ordinary shares, 0.0025 par value per share: 76,898,831 shares authorized; 72,308,930 and 72,197,286 shares issued and outstanding at March 31, 2022 and June 30, 2021, respectively |
CommonStockValue
|
$220.00K | USD | Point-in-time |
| Ordinary shares, 0.0025 par value per share: 76,898,831 shares authorized; 72,308,930 and 72,197,286 shares issued and outstanding at March 31, 2022 and June 30, 2021, respectively |
CommonStockValue
|
$220.00K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$150.41M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$153.60M | USD | Point-in-time |
| Accumulated other comprehensive income (loss) |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$3.16M | USD | Point-in-time |
| Accumulated other comprehensive income (loss) |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$8.28M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-87.44M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-127.56M | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquity
|
$59.97M | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquity
|
$71.46M | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquity
|
$29.41M | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquity
|
$80.03M | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquity
|
$86.90M | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquity
|
$45.80M | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquity
|
$87.12M | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquity
|
$15.91M | USD | Point-in-time |
| Total liabilities and shareholders' equity |
LiabilitiesAndStockholdersEquity
|
$78.58M | USD | Point-in-time |
| Total liabilities and shareholders' equity |
LiabilitiesAndStockholdersEquity
|
$44.47M | USD | Point-in-time |
Income Statement
96 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Revenue |
Revenues
|
$1.02M | USD | 3 Qtrs |
| Revenue |
Revenues
|
$812.00K | USD | 1 Quarter |
| Revenue |
Revenues
|
$619.00K | USD | 1 Quarter |
| Revenue |
Revenues
|
$2.14M | USD | 3 Qtrs |
| Cost of revenue |
CostOfRevenue
|
$1.40M | USD | 3 Qtrs |
| Cost of revenue |
CostOfRevenue
|
$426.00K | USD | 3 Qtrs |
| Cost of revenue |
CostOfRevenue
|
$685.00K | USD | 1 Quarter |
| Cost of revenue |
CostOfRevenue
|
$169.00K | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$127.00K | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$593.00K | USD | 3 Qtrs |
| Gross profit |
GrossProfit
|
$450.00K | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$735.00K | USD | 3 Qtrs |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$3.89M | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$7.31M | USD | 3 Qtrs |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$12.02M | USD | 3 Qtrs |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$3.10M | USD | 1 Quarter |
| General and administrative |
GeneralAndAdministrativeExpense
|
$10.81M | USD | 1 Quarter |
| General and administrative |
GeneralAndAdministrativeExpense
|
$5.55M | USD | 1 Quarter |
| General and administrative |
GeneralAndAdministrativeExpense
|
$29.01M | USD | 3 Qtrs |
| General and administrative |
GeneralAndAdministrativeExpense
|
$16.26M | USD | 3 Qtrs |
| Performance of contract liability to affiliate |
PerformanceOfContractLiabilityToAffiliate
|
$130.00K | USD | 1 Quarter |
| Performance of contract liability to affiliate |
PerformanceOfContractLiabilityToAffiliate
|
$889.00K | USD | 3 Qtrs |
| Performance of contract liability to affiliate |
PerformanceOfContractLiabilityToAffiliate
|
$163.00K | USD | 3 Qtrs |
| Performance of contract liability to affiliate |
PerformanceOfContractLiabilityToAffiliate
|
$32.00K | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$40.87M | USD | 3 Qtrs |
| Total operating expenses |
OperatingExpenses
|
$8.52M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$22.68M | USD | 3 Qtrs |
| Total operating expenses |
OperatingExpenses
|
$14.66M | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-40.13M | USD | 3 Qtrs |
| Loss from operations |
OperatingIncomeLoss
|
$-14.54M | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-8.07M | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-22.09M | USD | 3 Qtrs |
| Equity in net (losses) earnings of affiliate |
IncomeLossFromEquityMethodInvestments
|
$11.00K | USD | 3 Qtrs |
| Equity in net (losses) earnings of affiliate |
IncomeLossFromEquityMethodInvestments
|
$-229.00K | USD | 3 Qtrs |
| Equity in net (losses) earnings of affiliate |
IncomeLossFromEquityMethodInvestments
|
$-26.00K | USD | 1 Quarter |
| Equity in net (losses) earnings of affiliate |
IncomeLossFromEquityMethodInvestments
|
$-8.00K | USD | 1 Quarter |
| Foreign currency /gain (loss), net |
ForeignCurrencyTransactionGainLossBeforeTax
|
$-8.78M | USD | 3 Qtrs |
| Foreign currency /gain (loss), net |
ForeignCurrencyTransactionGainLossBeforeTax
|
$-1.09M | USD | 1 Quarter |
| Foreign currency /gain (loss), net |
ForeignCurrencyTransactionGainLossBeforeTax
|
$4.59M | USD | 3 Qtrs |
| Foreign currency /gain (loss), net |
ForeignCurrencyTransactionGainLossBeforeTax
|
$2.45M | USD | 1 Quarter |
| Fair value adjustment to VericiDx investment |
FairValueAdjustmentToVericidxInvestment
|
$-5.36M | USD | 3 Qtrs |
| Fair value adjustment to VericiDx investment |
FairValueAdjustmentToVericidxInvestment
|
$2.58M | USD | 1 Quarter |
| Fair value adjustment to VericiDx investment |
FairValueAdjustmentToVericidxInvestment
|
$-337.00K | USD | 1 Quarter |
| Fair value adjustment to VericiDx investment |
FairValueAdjustmentToVericidxInvestment
|
$4.60M | USD | 3 Qtrs |
| Other (expense) income, net |
OtherNonoperatingIncomeExpense
|
$228.00K | USD | 3 Qtrs |
| Other (expense) income, net |
OtherNonoperatingIncomeExpense
|
$61.00K | USD | 1 Quarter |
| Other (expense) income, net |
OtherNonoperatingIncomeExpense
|
$-4.00K | USD | 1 Quarter |
| Other (expense) income, net |
OtherNonoperatingIncomeExpense
|
$8.00K | USD | 3 Qtrs |
| Net loss |
NetIncomeLoss
|
$-7.61M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-8.78M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-9.13M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-40.12M | USD | 3 Qtrs |
| Net loss |
NetIncomeLoss
|
$-10.11M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-15.32M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-14.70M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-25.52M | USD | 3 Qtrs |
| Net loss attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
- | USD | 1 Quarter |
| Net loss attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-611.00K | USD | 3 Qtrs |
| Net loss attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
- | USD | 3 Qtrs |
| Net loss attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
- | USD | 1 Quarter |
| Net loss attributable to ordinary shareholders |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$-24.91M | USD | 3 Qtrs |
| Net loss attributable to ordinary shareholders |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$-8.78M | USD | 1 Quarter |
| Net loss attributable to ordinary shareholders |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$-40.12M | USD | 3 Qtrs |
| Net loss attributable to ordinary shareholders |
NetIncomeLossAvailableToCommonStockholdersBasic
|
$-14.70M | USD | 1 Quarter |
| Foreign exchange translation adjustment |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
$-2.63M | USD | 1 Quarter |
| Foreign exchange translation adjustment |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
$-5.12M | USD | 3 Qtrs |
| Foreign exchange translation adjustment |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
$1.16M | USD | 1 Quarter |
| Foreign exchange translation adjustment |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
$9.50M | USD | 3 Qtrs |
| Comprehensive loss |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$-7.61M | USD | 1 Quarter |
| Comprehensive loss |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$-45.24M | USD | 3 Qtrs |
| Comprehensive loss |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$-16.01M | USD | 3 Qtrs |
| Comprehensive loss |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$-17.33M | USD | 1 Quarter |
| Comprehensive loss attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$-72.00K | USD | 3 Qtrs |
| Comprehensive loss attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
- | USD | 1 Quarter |
| Comprehensive loss attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
- | USD | 3 Qtrs |
| Comprehensive loss attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
- | USD | 1 Quarter |
| Comprehensive loss attributable to Renalytix |
ComprehensiveIncomeNetOfTax
|
$-15.94M | USD | 3 Qtrs |
| Comprehensive loss attributable to Renalytix |
ComprehensiveIncomeNetOfTax
|
$-7.61M | USD | 1 Quarter |
| Comprehensive loss attributable to Renalytix |
ComprehensiveIncomeNetOfTax
|
$-45.24M | USD | 3 Qtrs |
| Comprehensive loss attributable to Renalytix |
ComprehensiveIncomeNetOfTax
|
$-17.33M | USD | 1 Quarter |
| Earnings Per Share, Basic |
EarningsPerShareBasic
|
$-0.12 | USD | 1 Quarter |
| Earnings Per Share, Basic |
EarningsPerShareBasic
|
$-0.35 | USD | 3 Qtrs |
| Earnings Per Share, Basic |
EarningsPerShareBasic
|
$-0.56 | USD | 3 Qtrs |
| Earnings Per Share, Basic |
EarningsPerShareBasic
|
$-0.20 | USD | 1 Quarter |
| Earnings Per Share, Diluted |
EarningsPerShareDiluted
|
$-0.12 | USD | 1 Quarter |
| Earnings Per Share, Diluted |
EarningsPerShareDiluted
|
$-0.20 | USD | 1 Quarter |
| Earnings Per Share, Diluted |
EarningsPerShareDiluted
|
$-0.56 | USD | 3 Qtrs |
| Earnings Per Share, Diluted |
EarningsPerShareDiluted
|
$-0.35 | USD | 3 Qtrs |
| Weighted Average Number of Shares Outstanding, Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
71.29M | shares | 3 Qtrs |
| Weighted Average Number of Shares Outstanding, Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
72.30M | shares | 1 Quarter |
| Weighted Average Number of Shares Outstanding, Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
72.27M | shares | 3 Qtrs |
| Weighted Average Number of Shares Outstanding, Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
72.04M | shares | 1 Quarter |
| Weighted Average Number of Shares Outstanding, Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
71.29M | shares | 3 Qtrs |
| Weighted Average Number of Shares Outstanding, Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
72.30M | shares | 1 Quarter |
| Weighted Average Number of Shares Outstanding, Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
72.04M | shares | 1 Quarter |
| Weighted Average Number of Shares Outstanding, Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
72.27M | shares | 3 Qtrs |
Cash Flow Statement
90 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
NetIncomeLoss
|
$-7.61M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-8.78M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-9.13M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-40.12M | USD | 3 Qtrs |
| Net loss |
NetIncomeLoss
|
$-10.11M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-15.32M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-14.70M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-25.52M | USD | 3 Qtrs |
| Gain on VericiDx deconsolidation |
DeconsolidationGainOrLossAmount
|
- | USD | 3 Qtrs |
| Gain on VericiDx deconsolidation |
DeconsolidationGainOrLossAmount
|
$46.00K | USD | 3 Qtrs |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$354.00K | USD | 3 Qtrs |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$182.00K | USD | 3 Qtrs |
| Share-based compensation |
ShareBasedCompensation
|
$1.66M | USD | 3 Qtrs |
| Share-based compensation |
ShareBasedCompensation
|
$2.88M | USD | 3 Qtrs |
| Realized gain on short-term investments |
DebtAndEquitySecuritiesRealizedGainLoss
|
$18.00K | USD | 3 Qtrs |
| Realized gain on short-term investments |
DebtAndEquitySecuritiesRealizedGainLoss
|
- | USD | 3 Qtrs |
| Equity in (net earnings) losses of affiliate |
IncomeLossFromEquityMethodInvestments
|
$11.00K | USD | 3 Qtrs |
| Equity in (net earnings) losses of affiliate |
IncomeLossFromEquityMethodInvestments
|
$-229.00K | USD | 3 Qtrs |
| Equity in (net earnings) losses of affiliate |
IncomeLossFromEquityMethodInvestments
|
$-26.00K | USD | 1 Quarter |
| Equity in (net earnings) losses of affiliate |
IncomeLossFromEquityMethodInvestments
|
$-8.00K | USD | 1 Quarter |
| Fair value adjustment to VericiDx investment |
FairValueAdjustmentToVericidxInvestment
|
$-5.36M | USD | 3 Qtrs |
| Fair value adjustment to VericiDx investment |
FairValueAdjustmentToVericidxInvestment
|
$2.58M | USD | 1 Quarter |
| Fair value adjustment to VericiDx investment |
FairValueAdjustmentToVericidxInvestment
|
$-337.00K | USD | 1 Quarter |
| Fair value adjustment to VericiDx investment |
FairValueAdjustmentToVericidxInvestment
|
$4.60M | USD | 3 Qtrs |
| Unrealized foreign exchange loss (gain) loss |
ForeignCurrencyTransactionGainLossUnrealized
|
$4.17M | USD | 3 Qtrs |
| Unrealized foreign exchange loss (gain) loss |
ForeignCurrencyTransactionGainLossUnrealized
|
$-5.55M | USD | 3 Qtrs |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-415.00K | USD | 3 Qtrs |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-68.00K | USD | 3 Qtrs |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-2.92M | USD | 3 Qtrs |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-1.95M | USD | 3 Qtrs |
| Receivable from affiliates |
IncreaseDecreaseInDueFromAffiliatesCurrent
|
$-143.00K | USD | 3 Qtrs |
| Receivable from affiliates |
IncreaseDecreaseInDueFromAffiliatesCurrent
|
- | USD | 3 Qtrs |
| Accounts payable |
IncreaseDecreaseInAccountsPayableTrade
|
$240.00K | USD | 3 Qtrs |
| Accounts payable |
IncreaseDecreaseInAccountsPayableTrade
|
$673.00K | USD | 3 Qtrs |
| Accounts payable - related party |
IncreaseDecreaseInAccountsPayableRelatedParties
|
$646.00K | USD | 3 Qtrs |
| Accounts payable - related party |
IncreaseDecreaseInAccountsPayableRelatedParties
|
- | USD | 3 Qtrs |
| Accrued expenses and other current liabilities |
IncreaseDecreaseInAccruedLiabilities
|
$2.09M | USD | 3 Qtrs |
| Accrued expenses and other current liabilities |
IncreaseDecreaseInAccruedLiabilities
|
$2.49M | USD | 3 Qtrs |
| Accrued expensesrelated party |
IncreaseDecreaseInAccruedExpensesRelatedParty
|
$4.89M | USD | 3 Qtrs |
| Accrued expensesrelated party |
IncreaseDecreaseInAccruedExpensesRelatedParty
|
$287.00K | USD | 3 Qtrs |
| Deferred revenue |
IncreaseDecreaseInDeferredRevenue
|
- | USD | 3 Qtrs |
| Deferred revenue |
IncreaseDecreaseInDeferredRevenue
|
$-55.00K | USD | 3 Qtrs |
| Payable to affiliate - current |
IncreaseDecreaseInDueToAffiliates
|
$-890.00K | USD | 3 Qtrs |
| Payable to affiliate - current |
IncreaseDecreaseInDueToAffiliates
|
$-163.00K | USD | 3 Qtrs |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$53.00K | USD | 3 Qtrs |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$-39.00K | USD | 3 Qtrs |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-23.30M | USD | 3 Qtrs |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-31.76M | USD | 3 Qtrs |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$879.00K | USD | 3 Qtrs |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$619.00K | USD | 3 Qtrs |
| Software development costs |
PaymentsToDevelopSoftware
|
$103.00K | USD | 3 Qtrs |
| Software development costs |
PaymentsToDevelopSoftware
|
$428.00K | USD | 3 Qtrs |
| Proceeds from short-term investments |
ProceedsFromSaleOfShortTermInvestments
|
- | USD | 3 Qtrs |
| Proceeds from short-term investments |
ProceedsFromSaleOfShortTermInvestments
|
$1.00M | USD | 3 Qtrs |
| Note receivable - related party |
ProceedsFromNotesReceivableRelatedParty
|
$167.00K | USD | 3 Qtrs |
| Note receivable - related party |
ProceedsFromNotesReceivableRelatedParty
|
- | USD | 3 Qtrs |
| Decrease in cash (VericiDx deconsolidation) |
CashDivestedFromDeconsolidation
|
$62.00K | USD | 3 Qtrs |
| Decrease in cash (VericiDx deconsolidation) |
CashDivestedFromDeconsolidation
|
- | USD | 3 Qtrs |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-722.00K | USD | 3 Qtrs |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-536.00K | USD | 3 Qtrs |
| Gross proceeds from the issuance of ordinary shares, net of underwriting fees |
GrossProceedsFromTheIssuanceOfOrdinarySharesNetOfUnderwritingFees
|
- | USD | 3 Qtrs |
| Gross proceeds from the issuance of ordinary shares, net of underwriting fees |
GrossProceedsFromTheIssuanceOfOrdinarySharesNetOfUnderwritingFees
|
$79.18M | USD | 3 Qtrs |
| Payment of offering costs |
PaymentOfFinancingAndStockIssuanceCosts
|
$2.31M | USD | 3 Qtrs |
| Payment of offering costs |
PaymentOfFinancingAndStockIssuanceCosts
|
- | USD | 3 Qtrs |
| Proceeds from the issuance of ordinary shares under employee share purchase plan |
ProceedsFromTheIssuanceOfOrdinarySharesUnderEmployeeSharePurchasePlan
|
$111.00K | USD | 3 Qtrs |
| Proceeds from the issuance of ordinary shares under employee share purchase plan |
ProceedsFromTheIssuanceOfOrdinarySharesUnderEmployeeSharePurchasePlan
|
$120.00K | USD | 3 Qtrs |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
- | USD | 3 Qtrs |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$197.00K | USD | 3 Qtrs |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$317.00K | USD | 3 Qtrs |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$76.99M | USD | 3 Qtrs |
| Effect of exchange rate changes on cash |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$-605.00K | USD | 3 Qtrs |
| Effect of exchange rate changes on cash |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.63M | USD | 3 Qtrs |
| Net (decrease) increase in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$56.78M | USD | 3 Qtrs |
| Net (decrease) increase in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-32.77M | USD | 3 Qtrs |
| Cash and cash equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$70.08M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$13.29M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$65.13M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$32.36M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$70.08M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$13.29M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$65.13M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$32.36M | USD | Point-in-time |
| Deemed distribution of VericiDx ordinary shares |
DeemedDistributionOfOrdinarySharesNonCashTransaction
|
$75.00K | USD | 3 Qtrs |
| Deemed distribution of VericiDx ordinary shares |
DeemedDistributionOfOrdinarySharesNonCashTransaction
|
- | USD | 3 Qtrs |
| Conversion of distribution of VericiDx note receivable into VericiDx ordinary shares |
ConversionOfNotesReceivableIntoOrdinaryShares
|
- | USD | 3 Qtrs |
| Conversion of distribution of VericiDx note receivable into VericiDx ordinary shares |
ConversionOfNotesReceivableIntoOrdinaryShares
|
$2.56M | USD | 3 Qtrs |
| Software development costs in accounts payable and accrued expenses |
SoftwareDevelopmentCostsIncurredButNotPaid
|
$195.00K | USD | 3 Qtrs |
| Software development costs in accounts payable and accrued expenses |
SoftwareDevelopmentCostsIncurredButNotPaid
|
- | USD | 3 Qtrs |
| Purchase of property and equipment in accounts payable and accrued expenses |
CapitalExpendituresIncurredButNotYetPaid
|
$31.00K | USD | 3 Qtrs |
| Purchase of property and equipment in accounts payable and accrued expenses |
CapitalExpendituresIncurredButNotYetPaid
|
$50.00K | USD | 3 Qtrs |
Stockholders Equity
44 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Beginning balance |
StockholdersEquity
|
$59.97M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$71.46M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$29.41M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$80.03M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$86.90M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$45.80M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$87.12M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$15.91M | USD | Point-in-time |
| Sale of ordinary shares, net of offering costs underwriting fees (Value) |
StockIssuedDuringPeriodValueNewIssues
|
$8.80M | USD | Point-in-time |
| Sale of ordinary shares, net of offering costs underwriting fees (Shares) |
StockIssuedDuringPeriodSharesNewIssues
|
2.22M | shares | Point-in-time |
| VericiDx noncontrolling interest upon deconsolidation |
NoncontrollingInterestDecreaseFromDeconsolidation
|
$2.30M | USD | 1 Quarter |
| Shares issued under the employee share purchase plan (Value) |
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
$120.00K | USD | 1 Quarter |
| Shares issued under the employee share purchase plan (Value) |
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
$111.00K | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$997.00K | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$525.00K | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$941.00K | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$631.00K | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$942.00K | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$501.00K | USD | 1 Quarter |
| Exercise of stock options (Value) |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$111.00K | USD | 1 Quarter |
| Exercise of stock options (Value) |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$86.00K | USD | 1 Quarter |
| Exercise of stock options (Shares) |
StockIssuedDuringPeriodSharesStockOptionsExercised
|
100,724.00 | shares | 3 Qtrs |
| Currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-2.58M | USD | 1 Quarter |
| Currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$1.16M | USD | 1 Quarter |
| Currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-2.63M | USD | 1 Quarter |
| Currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$97.00K | USD | 1 Quarter |
| Currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$2.19M | USD | 1 Quarter |
| Currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$6.08M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-7.61M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-8.78M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-9.13M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-40.12M | USD | 3 Qtrs |
| Net loss |
NetIncomeLoss
|
$-10.11M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-15.32M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-14.70M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-25.52M | USD | 3 Qtrs |
| Ending balance |
StockholdersEquity
|
$59.97M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$71.46M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$29.41M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$80.03M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$86.90M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$45.80M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$87.12M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$15.91M | USD | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.